放射介入栓塞化疗对肝癌合并门静脉癌栓治疗的疗效观察。

Transcatheter arterial chemoembolization therapy in the treatment of hepatocellular carcinoma with tumor thrombus of portal vein.

youdao

目的探讨肝癌合并门静脉癌栓的手术疗效，评价术中门静脉癌栓取出术和术后辅助肝动脉栓塞化疗对提高肝癌术后生存率的影响。

Objective To explore the value of removing portal vein tumor thrombus (PVTT) and TACE in improving the outcome of resection for primary liver cancer with PVTT.

youdao

结果：有28例发现肝脏灌注异常影像表现（21.1%，28/133），以原发性肝细胞癌为多见（22.5%，20/89），尤其是合并门静脉癌栓的肝癌病例（46.2%，12/26）。

Results:28 cases were found to have hepatic perfusion disorders(21.1%, 28/133). The common cause was HCC(22.5%, 20/89), especially HCC with portal vein tumor thrombus(46.2%, 12/26).

youdao

结果：有28例发现肝脏灌注异常影像表现（21.1%，28/133），以原发性肝细胞癌为多见（22.5%，20/89），尤其是合并门静脉癌栓的肝癌病例（46.2%，12/26）。

Results:28 cases were found to have hepatic perfusion disorders(21.1%, 28/133). The common cause was HCC(22.5%, 20/89), especially HCC with portal vein tumor thrombus(46.2%, 12/26).

youdao